叶加，女，博士，博士后，教授。1993年上海中医药大学获医学博士学位，1993-1995北京医科大学基础医学院从事分子生物学博士后研究工作。1995-1996中国医学科学院基础医学研究所医学分子生物学国家重点实验室进行分子免疫学研究。1997获日本长寿振兴财团基金，在WHO日本东京都老人综合研究所从事免疫研究工作，寻找类风湿性关节炎病理基因，探讨免疫耐受与自身免疫病发病机制的关系。近年主要从事神经免疫药理学、中药药理学的研究。主编和参编药理学、中药学相关著作10部。主持和参加国家自然科学基金、北京市自然科学基金、国家“973”和“十一五”等科研项目。在国际上首次发现体内镇痛抗炎新靶点---外周a7nAChR/M4AChR，及相关信号通路。激活a7nAChR与M4AChR可引起较强的镇痛抗炎作用而无明显毒副作用。近年以责任作者发表国外SCI和国内核心杂志科研论文30余篇，申请及授权世界专利4项和中国专利9项。

研究方向：

中药药理，神经免疫药理

研究课题：

1. 以外周a7nAChR为靶的镇痛抗炎药物研究

2. 活化a7nAChR/M4AchR后镇痛抗炎相关信号通路研究

3. 抗移植排斥药物及机制研究

4. 中药镇痛抗炎机制研究

5. 中药药性理论继承与创新研究

近年代表性论文：

1.    Qin Liu, Xiaoli Gao, Tianyu Wang, Xin Wang, Runtao Li, Yimin Jiang, Jia Ye* Effect and underlying mechanisms of spirocyclopiperazinium salt compound DXL-A-24 in rats following spinal nerve ligation Brain Research 2023, 1800: 148187
2.    Ning Li, Qin Liu, Run Tao Li, Qi Sun, Yi Min Jiang, Jia Ye* Anti-arthritic effect and underlying mechanism of the spirocyclopiperazinium salt compound LXM-15 in rats. Inflammation 2020, 43(3):903-915
3.    Ding Wang, Hua Yang, Yingying Liang, Xin Wang, Xiaolei Du, Runtao Li, Yimin Jiang, Jia Ye* Antinociceptive Effect of Spirocyclopiperazinium Salt Compound DXL-A-24 and underlying mechanism Neurochemical Research 2019, 44:2786–2795
4.    Hua Yang, Qi Sun, Yingying Liang ,Yimin Jiang, Runtao Li, Jia Ye* Antinociception of the spirocyclopiperazinium salt compound LXM-15 via activating α7 nAChR and M4 mAChR and inhibiting CaMKIIα/cAMP/CREB/CGRP signalling pathway in mice Regulatory Toxicology and Pharmacology 2018, 94: 108–114
5.    Xiaoli Gao,Qi Sun,Weiwei Zhang, Yimin Jiang，Runtao Li,Jia Ye* Anti-inflammatory effect and mechanism of the spirocyclopiperazinium salt compound LXM-15 in rats and mice Inflammation research 2018 67:363-370
6.    Wei-Wei Zhang, Feng Xub, Ding Wang,Jia Ye*, Shao-Qing Cai* Buyang Huanwu Decoction ameliorates ischemic stroke by modulating multiple targets with multiple components in vitro Chinese Journal of Natural Medicines 2018, 16（3）: 194-202
7.     Dan Wan, Ding Wang, Qi Sun, Yan Song, YiMin Jiang, RunTao Li, Jia Ye*. Antinociception of spirocyclopiperazinium salt compound LXM-10-M targeting α7 nicotinic receptor and M4 muscarinic recaptor and inhibiting CaMKII？/CREB/CGRP signaling pathway in mice.European Journal of Pharmacology 2016, 770: 92–98
8.     Xiaoli Gao, Hua Yang,Yangguang Xu,Yulan Xiong, Guannan Wang, Xinshan Ye, Jia Ye* Iminosugar derivative WGN-26 suppresses acute allograft rejection via inhibiting the IFN-γ/p-STAT1/T-bet signaling pathway. International Immunopharmacology 2014, 23: 688-695
9.      Weiwei Zhang, Qi Sun, Xiaoli Gao, Yimin Jiang, Runtao Li, Jia Ye*，Anti-Inflammation of Spirocyclopiperazinium Salt Compound LXM-10 Targeting α7 nAChR and M4 mAChR and Inhibiting JAK2/STAT3 Pathway in Rats. PLOS ONE 2013, 8(6):1-8 (8: e66895)
10.      Xia Zhao, Jia Ye*, Qi Sun, Yulan Xiong, Runtao Li and Yimin Jiang Antinociceptive effect of spirocyclopiperazinium salt compound LXM-15 via activating peripheral α7 nAChR and M4 mAChR in mice. Neuropharmacology 2011, 60:446-452
11.     Song-Wen Lin, Qi Sun, Ze-Mei Ge, Xin Wang, Jia Ye*, Run-Tao Li* Synthesis and structure-analgesic activity relationships of a novel series of monospirocyclopiperazinium salts (MSPZ). Bioorganic & Medicinal Chemistry Letters 2011, 21: 940–943
12.      Yulan Xiong, Xia Zhao, Qi Sun, Runtao Li, Changling Li, Jia Ye*，Antinociceptive mechanism of the spirocyclopiperazinium compound LXM-10 in mice and rats. Pharmacol. Biochem. Behav. 2010, 95:192–197
13.      Yulan Xiong, Jia Ye*, Qi Sun, Xia Zhao, Runtao Li, Yimin Jiang, Anti-inflammatory effect of the spirocyclopiperazinium compound LXM-10 in mice and rats. European Journal of Pharmacology 2010, 626: 290–296
14.      Guo-Liang Zhang, Changshui Chen, Yulan Xiong, Jia Ye*，Xin-Shan Ye*，Synthesis of N-substituted iminosugar derivatives and their immunosuppressive activities. Carbohydrate Research 2010, 345: 780–786
15.      Deng-Bo Ji,Jia Ye*, Chang-Ling Li, Yu-Hua Wang, Jiong Zhao and Shao-Qing Cai Antiaging Effect of Cordyceps sinensis Extract. Phytotherapy Research 2009, 23:116–122
16.      Deng-Bo Ji, Jia Ye*, Yi-Min Jiang and Bo-Wen Qian Anti-tumor effect of Liqi, a traditional Chinese medicine prescription, in tumor bearing mice.BMC Complementary and Alternative Medicine 2009, 9:20
17.      Deng Bo Ji, Chang Ling Li, Jia Ye*, Hai Bo Zhu* Effect of Hydroxysafflor yellow A on Human Umbilical Vein Endothelial Cells under hypoxia. Vascular Pharmacology 2009, 50: 137–145
18.     Ji DB, Zhu MC, Zhu B, Zhu YZ, Li CL,Ye J*, Zhu HB*, Hydroxysafflor yellow A enhances survival of vascular endothelial cells under hypoxia via upregulation of the HIF-1 alpha-VEGF pathway and regulation of Bcl-2/Bax. J Cardiovasc Pharmacol 2008, 52 (2) :191-202
19.     Deng Bo JI, Hai Bo ZHU, Jia YE*, Chang Ling LI* Establishment of a Cell-Based Assay to Screen Regulators of the Hypoxia-Inducible Factor-1-Dependent Vascular Endothelial Growth Factor promoter. Biol. Pharm. Bull. 2008, 31(12): 2255–2259
20.     Cai-Qin Yue, Jia Ye*, Chang-Ling Li, Run-Tao Li, Qi Sun. Antinociceptive effects of the novel spirocyclopiperazinium salt compound LXM -10 in mice. Pharmacol. Biochem. Behav. 2007, 86:643–650.